An article about Steve Pascolo and his contributions to the development of mRNA vaccines was published yesterday in “NZZ am Sonntag”. Steve Pascolo is group leader at the Dermatology Clinic of the University Hospital Zurich and head of the URPP Translational Cancer mRNA platform. He is an associate member of the NCCR RNA & Disease network since 2017.